← Leaderboards
Philip J Youngman
Elitra Pharmaceuticals, Inc.
$209,379
Attributed
$209,379
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$209,379 · 2
By mechanism
R43$209,379 · 2
Top collaborators
No co-investigators on record.
Most similar at Elitra Pharmaceuticals, Inc.
Same institution · by research overlap
- Robert J Haselbeck$3,943,980
- John D. Trawick$1,076,935
Others in their field
Top investigators on “Bacterial Genetics”
- Jay D Keasling · University Of California-Berkeley$37,866,508
- Stephan R. Targan · Cedars-Sinai Medical Center$34,669,247
- Thomas C. Terwilliger · University Of Calif-Los Alamos Nat Lab$34,552,873
- Scott J Hultgren · Washington University$30,511,148
- Ramnik J Xavier · Broad Institute, Inc.$28,881,442
- Pieter J. De Jong · Children'S Hospital &Res Ctr At Oakland$24,997,953
Research focus
Bacterial GeneticsAntibioticsBacillus AnthracisBiochemical EvolutionChemical Registry /ResourceClinical ResearchDrug Discovery /IsolationDrug Screening /EvaluationEscherichia ColiGenetic Promoter ElementHigh Throughput TechnologyInformaticsMicroarray TechnologyMolecular Biology Information SystemMolecular CloningPharmacokineticsPlasmidsStaphylococcus AureusTechnology /Technique DevelopmentTransfection /Expression VectorAntisense Nucleic Acid